Stocks making the biggest moves midday: AMD, Archer Aviation, SpaceX, Iren & more

The cleaner signal is not the headline pop in AI names; it is that hyperscalers are still willing to multi-source silicon and lock in capacity even after a tough tape. That improves AMD’s negotiating leverage with cloud buyers and raises the odds of a broader re-rating for second-tier AI suppliers such as MRVL and MU, but it also caps the idea that any one vendor owns the spend. For MSFT, the market should treat this as capex efficiency rather than incremental demand: the real benefit is optionality and supply assurance, not a step-change in Azure growth.

The more investable setup is in contracted AI infrastructure cash flows. IREN and HUT move from “story stock” to financing/lease execution stories, which should compress discount rates if management can show power, counterparty, and utilization are locked in; that is a 3-12 month catalyst, not a one-day trade. The risk is dilution or stranded-capacity economics if power costs or customer concentration worsen, so the thesis dies quickly if future ARR guidance outruns actual contracted backlog or margins lag even as revenue scales.

On the consumer side, the movie-theater move looks more like event-driven utilization than a durable demand reset. IMAX has the strongest leverage because premium format scarcity can preserve pricing power, while AMC/CNK are more exposed to ephemeral volume spikes and should fade if subsequent weekends normalize. The restaurant selloff in CAVA/SG is a classic near-term traffic overhang: if the FDA investigation broadens or lingers past a couple of weeks, it can hit comps and unit economics; if not, the drawdown should mean-revert fast. The contrarian risk in AI is that the market may be overrewarding any contract announcement without separating gross bookings from free cash flow conversion and dilution risk.